FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895099661> ?p ?o ?g. }

• W2895099661 endingPage "286" @default.
• W2895099661 startingPage "275" @default.
• W2895099661 abstract "Abstract Breast cancer is the most common type of diagnosed cancers in women, difficult to treat, and has received international attention because of its aggressive nature and inherent drug resistance mechanisms. Development of a better selective estrogen receptor modulator with good therapeutic profile and less toxicity is very crucial in this scenario. This study was undertaken to evaluate and compare the in vitro and in vivo antitumor activities of ormeloxifene with other clinically used breast cancer drugs. Cytotoxic activity of ormeloxifene was compared with standard drugs, 4‐hydroxytamoxifene and Adriamycin. Ormeloxifene (50 μM) concentration showed cytotoxicity of 75% and 82% in MDAMB‐231 and 24% and 80% in MCF‐7 cells, respectively, after 72 and 144 hr of incubation as displayed by cell viability assay. The same concentration of ormeloxifene was shown to exert 74% caspase‐7 activation in MCF‐7 cells after 24 hr of incubation by fluorescence resonance energy transfer assay. Cell cycle analysis proved that there was an increase in sub‐G1 peak to 64.4% and 33.9% in MDAMB‐231 and MCF‐7 cells, respectively, after treatment using ormeloxifene (50 μM) for 48 hr. The nonobese diabetic‐severe combined immunodeficiency mice bearing tumor xenografts of triple negative MDAMB‐231 cells treated with ormeloxifene (3 mg/kg bw) showed significant regression in relative tumor volume compared to control. From the results obtained and as evidenced from prior literature, ormeloxifene in addition to contraceptive use, can be repositioned for the development of an efficacious anticancer drug. These data present the preclinical part of a well concerted effort to place ormeloxifene into further clinical trials." @default.
• W2895099661 created "2018-10-12" @default.
• W2895099661 creator A5009151658 @default.
• W2895099661 creator A5020313265 @default.
• W2895099661 creator A5046024973 @default.
• W2895099661 creator A5046540153 @default.
• W2895099661 creator A5067990498 @default.
• W2895099661 creator A5072392145 @default.
• W2895099661 creator A5077680873 @default.
• W2895099661 creator A5082133426 @default.
• W2895099661 creator A5085883568 @default.
• W2895099661 date "2018-09-01" @default.
• W2895099661 modified "2023-09-26" @default.
• W2895099661 title "Nonhormonal selective estrogen receptor modulator 1-(2-[4-{(3R,4S)-7-Methoxy-2, 2-dimethyl-3-phenyl-chroman-4yl}phenoxy]ethyl)pyrrolidine hydrochloride (ormeloxifene hydrochloride) for the treatment of breast cancer" @default.
• W2895099661 cites W1598892184 @default.
• W2895099661 cites W1818165656 @default.
• W2895099661 cites W1918705397 @default.
• W2895099661 cites W1953520374 @default.
• W2895099661 cites W1964734680 @default.
• W2895099661 cites W1969511375 @default.
• W2895099661 cites W1970144459 @default.
• W2895099661 cites W1970642927 @default.
• W2895099661 cites W1979655678 @default.
• W2895099661 cites W1981577043 @default.
• W2895099661 cites W1984201118 @default.
• W2895099661 cites W2002257219 @default.
• W2895099661 cites W2007593622 @default.
• W2895099661 cites W2007756323 @default.
• W2895099661 cites W2015966835 @default.
• W2895099661 cites W2024726097 @default.
• W2895099661 cites W2026012871 @default.
• W2895099661 cites W2050831491 @default.
• W2895099661 cites W2063984088 @default.
• W2895099661 cites W2066199462 @default.
• W2895099661 cites W2080936300 @default.
• W2895099661 cites W2083266551 @default.
• W2895099661 cites W2084798667 @default.
• W2895099661 cites W2085748377 @default.
• W2895099661 cites W2098505104 @default.
• W2895099661 cites W2101302340 @default.
• W2895099661 cites W2116508133 @default.
• W2895099661 cites W2118728607 @default.
• W2895099661 cites W2120932072 @default.
• W2895099661 cites W2138171776 @default.
• W2895099661 cites W2154515919 @default.
• W2895099661 cites W2154792779 @default.
• W2895099661 cites W2161226294 @default.
• W2895099661 cites W2175607753 @default.
• W2895099661 cites W2179538534 @default.
• W2895099661 cites W2257695866 @default.
• W2895099661 cites W2257720117 @default.
• W2895099661 cites W2493188965 @default.
• W2895099661 cites W2600675143 @default.
• W2895099661 cites W2769024706 @default.
• W2895099661 cites W2792285007 @default.
• W2895099661 cites W4229780490 @default.
• W2895099661 doi "https://doi.org/10.1002/ddr.21440" @default.
• W2895099661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30284735" @default.
• W2895099661 hasPublicationYear "2018" @default.
• W2895099661 type Work @default.
• W2895099661 sameAs 2895099661 @default.
• W2895099661 citedByCount "5" @default.
• W2895099661 countsByYear W28950996612020 @default.
• W2895099661 countsByYear W28950996612021 @default.
• W2895099661 countsByYear W28950996612022 @default.
• W2895099661 crossrefType "journal-article" @default.
• W2895099661 hasAuthorship W2895099661A5009151658 @default.
• W2895099661 hasAuthorship W2895099661A5020313265 @default.
• W2895099661 hasAuthorship W2895099661A5046024973 @default.
• W2895099661 hasAuthorship W2895099661A5046540153 @default.
• W2895099661 hasAuthorship W2895099661A5067990498 @default.
• W2895099661 hasAuthorship W2895099661A5072392145 @default.
• W2895099661 hasAuthorship W2895099661A5077680873 @default.
• W2895099661 hasAuthorship W2895099661A5082133426 @default.
• W2895099661 hasAuthorship W2895099661A5085883568 @default.
• W2895099661 hasConcept C109316439 @default.
• W2895099661 hasConcept C121608353 @default.
• W2895099661 hasConcept C126322002 @default.
• W2895099661 hasConcept C185592680 @default.
• W2895099661 hasConcept C190283241 @default.
• W2895099661 hasConcept C202751555 @default.
• W2895099661 hasConcept C2777164284 @default.
• W2895099661 hasConcept C2777944059 @default.
• W2895099661 hasConcept C502942594 @default.
• W2895099661 hasConcept C530470458 @default.
• W2895099661 hasConcept C53227056 @default.
• W2895099661 hasConcept C55493867 @default.
• W2895099661 hasConcept C71924100 @default.
• W2895099661 hasConcept C84606932 @default.
• W2895099661 hasConcept C98274493 @default.
• W2895099661 hasConceptScore W2895099661C109316439 @default.
• W2895099661 hasConceptScore W2895099661C121608353 @default.
• W2895099661 hasConceptScore W2895099661C126322002 @default.
• W2895099661 hasConceptScore W2895099661C185592680 @default.
• W2895099661 hasConceptScore W2895099661C190283241 @default.
• W2895099661 hasConceptScore W2895099661C202751555 @default.
• W2895099661 hasConceptScore W2895099661C2777164284 @default.
• W2895099661 hasConceptScore W2895099661C2777944059 @default.

• next